In addition to suppressing cell viability, linsitinib treatment also inhibited the colony-forming ability in both types of RCC cells, and this inhibition appeared to be much stronger in MTAP KO cells versus WT 786-O cells (Fig. 6c). Here, MTAP is linked to renal cell carcinoma.